Omesti Bhd (XKLS:9008) Other Stockholders Equity: RM58.22 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Omesti Bhd Other Stockholders Equity?

Omesti Bhd XKLS:9008 +7.69% Other Stockholders Equity is RM58.22 Mil as of Apr. 2026. The stock has 5 warning signs investors should review.

Omesti Bhd's Other Stockholders Equity for the quarter that ended in Apr. 2026 was RM58.22 Mil.

Omesti Bhd's quarterly Other Stockholders Equity increased from Sep. 2025 (RM0.00 Mil) to Jan. 2026 (RM58.22 Mil) and increased from Jan. 2026 (RM58.22 Mil) to Apr. 2026 (RM58.22 Mil).

Omesti Bhd's annual Other Stockholders Equity declined from Mar. 2022 (RM50.85 Mil) to Mar. 2023 (RM50.54 Mil) and declined from Mar. 2023 (RM50.54 Mil) to Mar. 2024 (RM50.31 Mil).

Omesti Bhd Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Omesti Bhd's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omesti Bhd Other Stockholders Equity Chart

Omesti Bhd Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.91 51.57 50.85 50.54 50.31

Omesti Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Jan26 Apr26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.50 0.00 0.00 58.22 58.22

Omesti Bhd Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of RM58.22 Mil mean?
Omesti Bhd (XKLS:9008) has a Other Stockholders Equity of RM58.22 Mil as of Apr. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Omesti Bhd and its competitors.
Is Omesti Bhd's Other Stockholders Equity too high?
Omesti Bhd's current Other Stockholders Equity is RM58.22 Mil.
How does Omesti Bhd's Other Stockholders Equity compare to CTAS and CPRT?
Omesti Bhd's Other Stockholders Equity of RM58.22 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Business Services company?
A good Other Stockholders Equity depends on the Business Services industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Omesti Bhd and its competitors. Omesti Bhd's current Other Stockholders Equity is RM58.22 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omesti Bhd stock overvalued right now?
Based on GuruFocus' analysis, Omesti Bhd (XKLS:9008) is currently considered Modestly Overvalued. The stock's GF Value™ is RM0.06, compared to a current price of RM0.07 — trading 16.7% above its estimated fair value. The current Other Stockholders Equity is RM58.22 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Omesti Bhd (XKLS:9008), the current Other Stockholders Equity is RM58.22 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Omesti Bhd Business Description

Address No. 1 Persiaran Jalil 1, Bandar Bukit Jalil, 2-07-01 - Level 7, Plaza Bukit Jalil, Ho Hup Tower - Aurora Place, Kuala Lumpur, SGR, MYS, 57000
Omesti Bhd is focused on the delivery of technology solutions, systems integration services and the provision of recurring maintenance and managed services, predominantly for government and public sector customers. Its segments include Business Performance Services engages in provision of business performance improvement related services; Digital and Infrastructure Services engaged in the provision of a comprehensive range of tele/data communication, networking solutions and related services; and Healthcare Services engaged in the distribution of pharmaceutical products, vaccines and medical devices and provision of various medical services. The majority of the revenue is derived from Business Performance Services segment.